Diagnosis of X-linked adrenoleukodystrophy in blood leukocytes

Clinical Biochemistry

Volumn 40, Issue 13-14, 2007, Pages 1037-1044

  Unterberger, Ursula ^a   Regelsberger, Günther ^a   Sundt, Regina ^a   Bernheimer, Hanno ^a   Voigtländer, Till ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adrenoleukodystrophy protein; ALDP; Gas chromatography mass spectrometry; GC MS; Immunofluorescence; Very long chain fatty acids; X ALD; X linked adrenoleukodystrophy

Indexed keywords

VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LEUKOCYTE; MALE; MASS SPECTROMETRY; MONONUCLEAR CELL; MOSAICISM; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; ATP-BINDING CASSETTE TRANSPORTERS; FATTY ACIDS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HETEROZYGOTE; HUMANS; LEUKOCYTES; MALE; MICROSCOPY, FLUORESCENCE; PLASMA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34548131048     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.04.015     Document Type: Article

References (21)

1. Moser H.W., Kirby D.S., Watkins P.A., Powers J., and Moser A.B. X-linked adrenoleukodystrophy. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 3257-3301
2. van Geel B.M., Assies J., Wanders R.J., and Barth P.G. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J. Neurol. Neurosurg. Psychiatry 63 (1997) 4-14
3. Peters C., Charnas L.R., Tan Y., et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104 (2004) 881-888
4. Moser H.W. Therapy of X-linked adrenoleukodystrophy. NeuroRx 3 (2006) 246-253
5. Watkins P.A., Gould S.J., Smith M.A., et al. Altered expression of ALDP in X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 57 (1995) 292-301
6. Feigenbaum V., Lombard-Platet G., Guidoux S., Sarde C.O., Mandel J.L., and Aubourg P. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 58 (1996) 1135-1144
7. Boehm C.D., Cutting G.R., Lachtermacher M.B., Moser H.W., and Chong S.S. Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol. Genet. Metab. 66 (1999) 128-136
8. Vreken P., van Lint A.E., Bootsma A.H., Overmars H., Wanders R.J., and van Gennip A.H. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J. Chromatogr., B, Biomed. Sci. Appl. 713 (1998) 281-287
9. Moser H.W., Moser A.B., Frayer K.K., et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 31 (1981) 1241-1249
10. Antoku Y., Ohtsuka Y., Nagara H., et al. A comparison of erythrocytes, lymphocytes and blood plasma as samples in fatty acid analysis for the diagnosis of adrenoleukodystrophy. J. Neurol. Sci. 94 (1989) 193-200
11. Antoku Y., Koike F., Ohtsuka Y., et al. Adrenoleukodystrophy: a correlation between saturated very long-chain fatty acids in mononuclear cells and phenotype. Ann. Neurol. 30 (1991) 101-103
12. Molzer B. Diagnosis of peroxisomal disorders with neurological involvement. Padiatr. Padol. 28 (1993) 43-48
13. Schutgens R.B., Bouman I.W., Nijenhuis A.A., Wanders R.J., and Frumau M.E. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Clin. Chem. 39 (1993) 1632-1637
14. Kawamura N., Moser A.B., Moser H.W., et al. High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. Biochem. Biophys. Res. Commun. 82 (1978) 114-120
15. Moser H.W., Moser A.B., Kawamura N., et al. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann. Neurol. 7 (1980) 542-549
16. Molzer B., Bernheimer H., and Toifl K. Fatty acid patterns in brain, fibroblast, leukocyte and body fluid lipids in adrenoleukodystrophy. Acta Neuropathol. Suppl. (Berl.) 7 (1981) 211-214
17. Molzer B., Bernheimer H., Heller R., Toifl K., and Vetterlein M. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes. Clin. Chim. Acta 125 (1982) 299-305
18. Tsuji S., Suzuki M., Ariga T., Sekine M., Kuriyama M., and Miyatake T. Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J. Neurochem. 36 (1981) 1046-1049
19. Moser A.B., Kreiter N., Bezman L., et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45 (1999) 100-110
20. Wanders R.J., van Roermund C.W., Lageweg W., et al. X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. J. Inherit. Metab. Dis. 15 (1992) 634-644
21. Kennedy C.R., Allen J.T., Fensom A.H., Steinberg S.J., and Wilson R. X-linked adrenoleukodystrophy with non-diagnostic plasma very long chain fatty acids. J. Neurol. Neurosurg. Psychiatry 57 (1994) 759-761